If your immune system is weakened, you are at a higher risk for infections such as Covid-19. Joining a clinical trial studying new medicines or vaccines can be crucial in protecting immunocompromised individuals.
Understanding “immunocompromised”
Individuals who are “immunocompromised” have a weakened immune system, making it harder for them to fight off viruses and bacteria.
Causes of weakened immunity
There are various reasons for a weakened immune system, including health conditions, primary immune deficiency, certain medications, and age.
Covid-19 threats to immunocompromised individuals
- Immunocompromised individuals are at greater risk of contracting Covid-19 and are more likely to experience severe illness if infected.
- Vaccines may not be as effective in individuals with weakened immune systems.
- New strains of Covid-19 pose an increased risk to immunocompromised individuals.
Protecting immunocompromised individuals from Covid-19
- Healthy habits – Improve air filtration, maintain hygiene, and wear masks.
- Personal health – Be vigilant for symptoms and contact a healthcare provider if needed.
- Vaccination – It is crucial for immunocompromised individuals to stay up to date with Covid-19 vaccines.
- Treatment – Specific treatments are available for immunocompromised individuals with Covid-19.
Importance of clinical trials for immunocompromised individuals
- Previous research on Covid-19 treatments and vaccines did not include immunocompromised individuals, making their participation crucial in answering key questions.
- Participation in a clinical trial may provide access to medicines that could protect against the effects of Covid-19.
Safety of clinical trials for immunocompromised individuals
Clinical trials are closely monitored to ensure ethical and appropriate research practices.
Finding a Covid-19 clinical trial
- Resources such as ClinicalTrials.gov and NIAID Covid-19 Studies can help individuals find relevant clinical trials for Covid-19 treatment.
This educational resource was created with support from AstraZeneca.
